Cargando…

Eculizumab Dosing in Infants

Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome (aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children and 5 infants) and one prospective trial (22 patients and 5 infants). This case report highlights the need for more preci...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobrzynski, M., Wile, B., Huang, S. S., Filler, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830814/
https://www.ncbi.nlm.nih.gov/pubmed/29515306
http://dx.doi.org/10.4103/ijn.IJN_310_16